Keywords: safety, pharmacokinetics, pharmacodynamics, Japanese, apixaban, anticoagulation, Asian, novel, Eliquis Introduction Apixaban (BMS-562247) is an orally bioavailable, selective inhibitor of coagulation factor Xa (FXa) that directly and reversibly binds to the active site of FXa, exerting anticoagulant and antithrombotic effects by diminishing the conversion of prothrombin to thrombin
Method Development for Size-Exclusion Chromatography of Monoclonal Antibodies and Higher Order Aggregates
Neuronal survival benefits accrue over months to years as protected cells outlive those that would have died
The principles are identical
T., Kumar, M., Xiong, S
NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions